Cargando…

Amyloid β and Alzheimer’s Disease: Molecular Updates from Physiology to Pathology

Detalles Bibliográficos
Autor principal:	Giuffrida, Maria Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178307/ https://www.ncbi.nlm.nih.gov/pubmed/37175620 http://dx.doi.org/10.3390/ijms24097913

Ejemplares similares

Alzheimer’s disease amyloid-β pathology in the lens of the eye
por: Moncaster, Juliet A., et al.
Publicado: (2022)

The Dichotomy of Alzheimer’s Disease Pathology: Amyloid-β and Tau
por: Ashford, J. Wesson
Publicado: (2019)

A promising connection between BDNF and Alzheimer’s disease
por: Giuffrida, Maria Laura, et al.
Publicado: (2018)

Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer’s Disease Therapeutics
por: Jeong, Hyomin, et al.
Publicado: (2022)

JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology
por: Solas, Maite, et al.
Publicado: (2023)

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
por: Ferrari-Souza, João Pedro, et al.
Publicado: (2022)

Editorial: Targets for Disease-Modifying Therapies in Alzheimer’s Disease, Including Amyloid β and Tau Protein
por: Parums, Dinah V.
Publicado: (2021)

Alzheimer's Disease Amyloid-β Links Lens and Brain Pathology in Down Syndrome
por: Moncaster, Juliet A., et al.
Publicado: (2010)

Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease
por: Dawkins, Edgar, et al.
Publicado: (2014)

CSF β-amyloid and white matter damage: unravelling the neuropathology of Alzheimer’s disease
por: Sousa Alves, Gilberto
Publicado: (2018)

Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology
por: Thal, Dietmar R.
Publicado: (2015)

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2021)

LISPRO mitigates β-amyloid and associated pathologies in Alzheimer’s mice
por: Habib, Ahsan, et al.
Publicado: (2017)

Physiological or Pathological Molecular Alterations in Brain Aging
por: Morabito, Rossana, et al.
Publicado: (2022)

The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview
por: Morelli, Laura, et al.
Publicado: (2012)

The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
por: Brothers, Holly M., et al.
Publicado: (2018)

Characterization of a Novel Mouse Model of Alzheimer’s Disease—Amyloid Pathology and Unique β-Amyloid Oligomer Profile
por: Liu, Peng, et al.
Publicado: (2015)

Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
por: Pfundstein, Grant, et al.
Publicado: (2022)

Physiological and pathological effects of amyloid-β species in neural stem cell biology
por: Bernabeu-Zornoza, Adela, et al.
Publicado: (2019)

Beyond amyloid: New approaches to Alzheimer's disease treatment
Publicado: (2020)

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
por: Bellaver, Bruna, et al.
Publicado: (2023)

Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
por: Paris, Daniel, et al.
Publicado: (2010)

Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer’s disease–like mice
por: Prokop, Stefan, et al.
Publicado: (2015)

Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease
por: Raimundo, Ana F., et al.
Publicado: (2020)

Misfolded amyloid-β strains and their potential roles in the clinical and pathological variability of Alzheimer’s disease
por: Kelley, Sara, et al.
Publicado: (2022)

β-Amyloid Degradation and Alzheimer's Disease
por: Wang, Deng-Shun, et al.
Publicado: (2006)

Mitochondria, Amyloid β, and Alzheimer's Disease
por: Readnower, Ryan D., et al.
Publicado: (2011)

The Amyloid-β Pathway in Alzheimer’s Disease
por: Hampel, Harald, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
por: Kehoe, Patrick Gavin, et al.
Publicado: (2016)

Amyloid-β oligomers set fire to inflammasomes and induce Alzheimer's pathology
por: Salminen, Antero, et al.
Publicado: (2008)

Mitochondria: From Physiology to Pathology
por: Bruni, Francesco
Publicado: (2021)

The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics
por: Kent, Sarah A., et al.
Publicado: (2020)

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease
por: Toombs, Jamie, et al.
Publicado: (2020)

Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology
por: Hefner, Marleigh, et al.
Publicado: (2021)

Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer’s disease
por: Frigerio, Irene, et al.
Publicado: (2021)

Sodium rutin ameliorates Alzheimer’s disease–like pathology by enhancing microglial amyloid-β clearance
por: Pan, Rui-Yuan, et al.
Publicado: (2019)

Regional differences in Alzheimer’s disease pathology confound behavioural rescue after amyloid-β attenuation
por: Morrone, Christopher D, et al.
Publicado: (2020)

New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease
por: Park, Sun Ah, et al.
Publicado: (2020)

Activation of CREB‐mediated autophagy by thioperamide ameliorates β‐amyloid pathology and cognition in Alzheimer’s disease
por: Wang, Jiangong, et al.
Publicado: (2021)

Synthetic amyloid-β oligomers drive early pathological progression of Alzheimer’s disease in nonhuman primates
por: Yue, Feng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ld85atnq9ooahv3kmr70m8i02